Sawa Ito, Md
Clinical trials sponsored by Sawa Ito, Md, explained in plain language.
-
New transplant cocktail aims to tame blood cancer without severe side effects
Disease control Recruiting nowThis early-stage trial is testing a new combination of chemotherapy drugs (thiotepa, busulfan, and fludarabine) followed by a stem cell transplant for people with certain blood cancers like leukemia and myelodysplastic syndrome. The goal is to see if this approach can reduce the …
Phase 1 • Sponsor: Sawa Ito, MD • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New combo therapy aims to beat back relapsed leukemia after transplant
Disease control Recruiting nowThis phase 2 trial tests whether combining interferon-gamma (a protein that boosts the immune system) with donor immune cells can help patients whose acute myeloid leukemia or myelodysplastic syndromes have returned after a stem cell transplant. The study will enroll 45 adults an…
Phase 2 • Sponsor: Sawa Ito, MD • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC